Insider Shareholders with Direct Ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR)
This section provides a comprehensive overview of the insiders with direct ownership of Eiger Bio Pharmaceuticals, Inc. (EIGR). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
Eiger BioPharmaceuticals, Inc. Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
| 111,000 | 0 | 182,355 $1.73 Million | 3 |
Dec 22, 2022
Added 35.42%
|
|
|
David A Cory
President and CEO |
94,000 | 0 | 169,183 $1.61 Million | 2 |
Mar 11, 2022
Added 21.74%
|
|
Eldon C. Mayer Iii
Ex VP & Chief Commerc. Officer |
27,875 | 9,302 | 56,073 $532,693 | 6 |
Mar 17, 2023
Reduced 3.24%
|
|
Sriram Ryali
Chief Financial Officer |
40,250 | 2,266 | 41,566 $394,877 | 3 |
Mar 14, 2022
Reduced 5.17%
|
|
James P Shaffer
Chief Business Officer |
11,875 | 0 | 29,296 $278,312 | 1 |
Mar 12, 2021
Added 28.84%
|
| 13,500 | 22,500 | 21,000 $199,500 | 4 |
Dec 22, 2022
Reduced 51.72%
|
|
|
Stephana Eilene Patton
Officer |
11,875 | 0 | 17,948 $170,506 | 1 |
Mar 12, 2021
Added 39.82%
|
| 11,000 | 0 | 16,000 $152,000 | 2 |
Mar 11, 2022
Added 27.27%
|
|
| 11,000 | 2,000 | 14,000 $133,000 | 3 |
Mar 11, 2022
Added 30.0%
|
|
|
David Apelian
CEO |
11,000 | 5,000 | 11,000 $104,500 | 3 |
Aug 16, 2022
Reduced 31.25%
|
| 11,000 | 5,000 | 11,000 $104,500 | 3 |
Dec 29, 2022
Reduced 31.25%
|
|
| 6,000 | 0 | 6,000 $57,000 | 1 |
Mar 11, 2022
Added 50.0%
|
|
|
Erik Atkisson
GC & Chief Compliance Officer |
6,000 | 0 | 6,000 $57,000 | 1 |
Mar 11, 2022
Added 50.0%
|